| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.8B | $0.9B | $0.7B | $0.1B | — | — | — |
| Cost of Revenue | $0.9B | $0.7B | $0.6B | $0.5B | $0.1B | $0.2B | $0.2B | — |
| Gross Profit | $-0.1B | $0.1B | $0.3B | $0.2B | $0.0B | $0.1B | $0.1B | $0.1B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B |
| Operating Income | $-1.3B | $-0.4B | $-0.4B | $-0.2B | $-0.3B | $-0.2B | $-0.0B | $-0.3B |
| Net Income | $-1.6B | $-0.9B | $-0.3B | $-0.2B | $-0.1B | $-0.0B | $-0.1B | $-0.0B |
| EPS (Basic) | $-11.39 | $-6.88 | $-2.65 | $-1.67 | $-1.28 | — | $-1.26 | $-0.33 |
| EPS (Diluted) | $-11.39 | $-6.88 | $-2.65 | $-1.67 | $-1.28 | — | $-1.26 | $-0.33 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.9B | $8.0B | $6.6B | $3.9B | $3.4B | $3.2B | $2.8B | $2.6B |
| Current Assets | $2.5B | $3.0B | $3.6B | $1.8B | $1.5B | $1.6B | $1.4B | $0.9B |
| Cash & Equivalents | $0.5B | $1.0B | $1.8B | $0.4B | $0.4B | $0.4B | $0.5B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $7.1B | $0.7B | $0.6B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B |
| Stockholders' Equity | $-0.4B | $0.9B | $1.6B | $2.4B | $2.1B | $2.1B | $2.0B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.7B | $-0.7B | $-0.1B | $-0.2B | $-0.1B | $-0.0B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.3B | $-1.9B | $-1.1B | $-0.4B | $-0.4B | $-0.5B | $-0.2B | $-0.4B |
| Capital Expenditures | $1.3B | $2.3B | $1.0B | $0.6B | $0.6B | $0.2B | $0.1B | $0.2B |
| Financing Cash Flow | $0.4B | $2.0B | $2.6B | $0.6B | $0.5B | $0.5B | $0.4B | $0.2B |